Warberg Asset Management’s Silexion Therapeutics SLXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$61.9K Buy
+9,394
New +$278K 0.01% 158

Other funds holding SLXN

Warberg Asset Management's SLXN Position: Q3 2026 in Review

Warberg Asset Management opened a new position in Silexion Therapeutics (SLXN) in Q3 2026: 9,394 shares worth $61.9K. The stake represents 0.01% of the portfolio and ranks #158 among its holdings.

10 funds tracked by Wall St. Rank hold SLXN as of Q3 2026.

  • Warberg Asset Management held 9,394 shares of Silexion Therapeutics worth $61.9K as of Q3 2026.
  • Silexion Therapeutics was a new Warberg Asset Management position in Q3 2026.
  • Silexion Therapeutics made up 0.01% of Warberg Asset Management's portfolio in Q3 2026, its #158 holding.
  • 10 funds tracked by Wall St. Rank held Silexion Therapeutics as of Q3 2026.

Based on Warberg Asset Management's 13F filing for Q3 2026, filed 2 Nov 2026.